Literature DB >> 7995939

Cell cycle control of apoptosis in human leukemic T cells.

L Zhu1, C Anasetti.   

Abstract

Eukaryotic cell cycle is regulated by feedback controls that can arrest the progress of the cell cycle at specific checkpoints. Failure of feedback controls may predispose cells to undergo apoptotic death in response to a variety of stimuli. Transformed cell lines often carry defects in one or more proteins that regulate cell cycle, and therefore can be used as a model to study how cell cycle controls cell death. The present study investigated whether TCR/CD3-induced apoptosis of human leukemic T cells is cell cycle dependent. Studies of Jurkat and Sup-T13, two human leukemic T cell lines, demonstrated that anti-CD3 Ab-driven activation results in a transient, reversible inhibition of DNA synthesis in Jurkat cells, but results in a persistent, irreversible inhibition of DNA synthesis in Sup-T13 cells. Anti-CD3 mAb blocked Jurkat cells at the G1/S interface without inducing cell death. In contrast, anti-CD3 mAb allowed Sup-T13 cells to enter S phase but inhibited progression into G2 phase and triggered cell death. Electron microscopy showed that anti-CD3 mAb-stimulated Sup-T13 cells acquired the characteristic morphology of apoptosis. The nuclear DNA appeared as oligonucleosome-sized fragments by gel electrophoresis, and as an apoptotic peak displaying lower fluorescence than the DNA content of cells in G1 phase by DNA flow microfluorometry. DNA fragmentation correlated with entry into S phase. The DNA synthesis inhibitor aphidicolin arrested Sup-T13 cells at the G1/S interface and prevented the apoptosis. Therefore, DNA synthesis is required for executing the apoptosis program initiated by TCR/CD3 stimulation of Sup-T13 cells. These data are consistent with the hypothesis that the suicide of activated cycling T cells upon encountering autoantigens may be one of the mechanisms for the immune system to prevent autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7995939

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle.

Authors:  M Karas; T Z Zaks; J L Liu; D LeRoith
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone.

Authors:  L L Delehanty; J A Payne; S N Farrow; R Brown; B R Champion
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

3.  Murine norovirus replication induces G0/G1 cell cycle arrest in asynchronously growing cells.

Authors:  Colin Davies; Chris M Brown; Dana Westphal; Joanna M Ward; Vernon K Ward
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

Review 4.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

5.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells.

Authors:  L Zhu; X Yu; Y Akatsuka; J A Cooper; C Anasetti
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

7.  Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori.

Authors:  U Knipp; S Birkholz; W Kaup; W Opferkuch
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Murine coronavirus replication induces cell cycle arrest in G0/G1 phase.

Authors:  Chun-Jen Chen; Shinji Makino
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  A novel noninvasive method to detect rejection after heart transplantation.

Authors:  Jun Hu; Xin Xie; Yuan Li; Shuang Wang; Qing Feng; Xin Wang; Daoyan Liang
Journal:  Braz J Med Biol Res       Date:  2012-10-16       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.